Executive Director Asset Team Lead
Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Funding history
About Recursion
Recursion Pharmaceuticals, Inc. is a public clinical-stage TechBio company headquartered in Salt Lake City, Utah. Its Recursion OS integrates biology, chemistry, clinical development, multimodal data, and purpose-built AI models.
Skills
Candidate Availability
Required and preferred rules are kept separate and reflect the wording in the original posting.
About the Role
You will define asset strategy for small-molecule clinical programs, translate computational insights into asset advantages, develop competitive narratives, and partner across functions to guide portfolio prioritization, resource allocation, and delivery of portfolio goals.
Requirements
- Drug discovery and development expertise
- Small-molecule therapeutic development expertise
- Oncology expertise
- Immunology and inflammation expertise
- Computational approaches
- Data-driven platform experience
- Competitive strategy
- Financial acumen
- Asset valuation
- Portfolio management
Responsibilities
- Define and drive asset strategy for small-molecule clinical programs
- Integrate competitive positioning, mechanistic differentiation, biomarker strategy, and patient segmentation
- Translate Recursion OS and ClinTech insights into strategic asset advantages
- Develop and pressure-test competitive narratives for portfolio assets
- Partner with functional leaders on resource allocation and portfolio priorities
- Advance differentiated assets for patients with unmet needs
Benefits
- Annual bonus
- Equity compensation
- Comprehensive benefits package